Stock listing
MTVA Stock Price, News, Filings & Events — Metavia Inc.
Selected listing: MTVA · BOATS · USD · US
This page tracks Metavia Inc.'s MTVA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MTVA:BOATS. MTVA:BOATS is the stock-level entry point for investors researching Metavia Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Metavia Inc. (Ticker: MTVA) is a public company operating in the American market, with a market capitalization of approximately $8.83 million. The company focuses on its core business activities and aims to deliver value to its stakeholders. Investors can find relevant information about Metavia's performance and strategic direction on its public company page.

- Ticker
- MTVA:BOATS
- Asset type
- Stock
- Market cap
- $10.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Metavia Inc. MTVA:BOATS stock context
This page tracks Metavia Inc.'s MTVA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MTVA:BOATS. MTVA:BOATS is the stock-level entry point for investors researching Metavia Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Metavia Inc. (Ticker: MTVA) is a public company operating in the American market, with a market capitalization of approximately $8.83 million. The company focuses on its core business activities and aims to deliver value to its stakeholders. Investors can find relevant information about Metavia's performance and strategic direction on its public company page.
Latest news from Metavia Inc.
MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
September 9, 2026
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
July 9, 2026
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and ...
June 8, 2026
MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
May 27, 2026
Research Metavia Inc.
Metavia Inc. investor report
Review AI stock analysis and investor report context for MTVA:BOATS.
Metavia Inc. company profile
View the public company page for Metavia Inc. on 6ix.
Metavia Inc. news
Read company news and market updates connected to Metavia Inc..
Metavia Inc. investor events
Find investor webinars, events, and replay context for Metavia Inc..